CoChat
Sign Up
Cited by 75

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease

Roy, Bidisha, Jackson, George R.·2014·Human Molecular Genetics
DOI 10.1093/hmg/ddu011
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddu011

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 115

  1. Morishima-Kawashima, 1995, Hyperphosphorylation of tau in PHF, Neurobiol. Aging, 16, 365, 10.1016/0197-4580(95)00027-C · DOI · Paper page
  2. Johnson, 2002, Tau, where are we now?, J. Alz. Dis., 4, 375, 10.3233/JAD-2002-4505 · DOI · Paper page
  3. Cookson, 2005, The biochemistry of Parkinson's disease, Annu. Rev. Biochem., 74, 29, 10.1146/annurev.biochem.74.082803.133400 · DOI
  4. Wersinger, 2005, Disruption of the interaction of α-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter, Biochemistry, 44, 13612, 10.1021/bi050402p · DOI
  5. Hamilton, 2000, Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry, Brain Pathol., 10, 378, 10.1111/j.1750-3639.2000.tb00269.x · DOI · Paper page
  6. Kotzbauer, 2001, Lewy body pathology in Alzheimer's disease, J. Mol. Neurosci., 17, 225, 10.1385/JMN:17:2:225 · DOI · Paper page
  7. Hishikawa, 2003, α-Synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification, Neuropath. Appl. Neurobiol., 29, 280, 10.1046/j.1365-2990.2003.00470.x · DOI
  8. Popescu, 2004, Lewy bodies in the amygdala: increase of α-synuclein aggregates in neurodegenerative diseases with tau-based inclusions, Arch. Neurol., 61, 1915, 10.1001/archneur.61.12.1915 · DOI
  9. Trembath, 2003, Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease, Acta Neuropathol., 105, 484, 10.1007/s00401-003-0670-9 · DOI
  10. Lippa, 2005, α-synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level, Am. J. Alz. Dem., 20, 315
  11. Lippa, 1999, Antibodies to α-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease, Ann. Neurol., 45, 353, 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4 · DOI
  12. Arima, 1999, Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies, Brain Res., 843, 53, 10.1016/S0006-8993(99)01848-X · DOI
  13. Ishizawa, 2003, Colocalization of tau and α-synuclein epitopes in Lewy bodies, J. Neuropathol. Exp. Neurol., 62, 389, 10.1093/jnen/62.4.389 · DOI
  14. Edwards, 2010, Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease, Ann. Hum. Genet., 74, 97, 10.1111/j.1469-1809.2009.00560.x · DOI
  15. Simon-Sanchez, 2009, Genome-wide association study reveals genetic risk underlying Parkinson's disease, Nat. Genet., 41, 1308, 10.1038/ng.487 · DOI · Paper page
  16. Devine, 2008, Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2, FEBS J., 275, 5748, 10.1111/j.1742-4658.2008.06707.x · DOI
  17. Duka, 2006, The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of α-synuclein, in SH-SY5Y neuroblastoma cells, Neurotox. Res., 10, 1, 10.1007/BF03033329 · DOI
  18. Duka, 2006, α-synuclein induces hyperphosphorylation of tau in the MPTP model of parkinsonism, FASEB J., 20, 2302, 10.1096/fj.06-6092com · DOI
  19. Duka, 2009, α-Synuclein contributes to GSK-3β-catalyzed tau phosphorylation in Parkinson's disease models, FASEB J., 23, 2820, 10.1096/fj.08-120410 · DOI
  20. Haggerty, 2011, Hyperphosphorylated tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease, Eur. J. Neurosci., 33, 1598, 10.1111/j.1460-9568.2011.07660.x · DOI
  21. Kotzbauer, 2004, Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation, Exp. Neurol., 187, 279, 10.1016/j.expneurol.2004.01.007 · DOI
  22. Trinh, 2008, Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease, J. Neurosci., 28, 465, 10.1523/JNEUROSCI.4778-07.2008 · DOI
  23. Jackson, 2002, Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila, Neuron, 34, 509, 10.1016/S0896-6273(02)00706-7 · DOI · Paper page
  24. Ambegaokar, 2010, Interaction between eye pigment genes and tau-induced neurodegeneration in Drosophila melanogaster, Genetics, 186, 435, 10.1534/genetics.110.119545 · DOI · Paper page
  25. Fan, 2010, Dual roles of Drosophila p53 in cell death and cell differentiation, Cell Death Diff., 17, 912, 10.1038/cdd.2009.182 · DOI
  26. Kato, 2009, Neuronal programmed cell death induces glial cell division in the adult Drosophila brain, Development, 136, 51, 10.1242/dev.023366 · DOI
  27. Betz, 2008, STAT92E is a positive regulator of Drosophila inhibitor of apoptosis 1 (DIAP/1) and protects against radiation-induced apoptosis, Proc. Natl. Acad. Sci. USA, 105, 13805, 10.1073/pnas.0806291105 · DOI
  28. Alonso, 2001, Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein, J. Biol. Chem., 276, 37967, 10.1074/jbc.M105365200 · DOI
  29. Abraha, 2000, C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease, J. Cell Sci., 113, 3737, 10.1242/jcs.113.21.3737 · DOI
  30. Jeannotte, 2008, Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons, J. Neurochem., 105, 1668, 10.1111/j.1471-4159.2008.05258.x · DOI
  31. Kotani, 1985, Calmodulin inhibits interaction of actin with MAP2 and Tau, two major microtubule-associated proteins, J. Biol. Chem., 260, 10779, 10.1016/S0021-9258(19)85149-9 · DOI
  32. Correas, 1990, The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding, Biochem. J., 269, 61, 10.1042/bj2690061 · DOI · Paper page
  33. Moraga, 1993, A tau fragment containing a repetitive sequence induces bundling of actin filaments, J. Neurochem., 61, 979, 10.1111/j.1471-4159.1993.tb03611.x · DOI · Paper page
  34. Henriquez, 1995, Subpopulations of tau interact with microtubules and actin filaments in various cell types, Cell Biochem. Funct., 13, 239, 10.1002/cbf.290130404 · DOI
  35. He, 2009, The proline-rich domain of tau plays a role in interactions with actin, BMC Cell Biol., 10, 81, 10.1186/1471-2121-10-81 · DOI · Paper page
  36. Hummel, 2000, Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development, Neuron, 26, 357, 10.1016/S0896-6273(00)81169-1 · DOI
  37. Ratnaparkhi, 2008, A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism, PLoS ONE, 3, e2334, 10.1371/journal.pone.0002334 · DOI
  38. Viquez, 2006, The B’ protein phosphatase 2A regulatory subunit well-rounded regulates synaptic growth and cytoskeletal stability at the Drosophila neuromuscular junction, J. Neurosci., 26, 9293, 10.1523/JNEUROSCI.1740-06.2006 · DOI
  39. Pennetta, 2002, Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner, Neuron, 35, 291, 10.1016/S0896-6273(02)00769-9 · DOI
  40. Packard, 2002, The Drosophila Wnt, wingless, provides an essential signal for pre- and postsynaptic differentiation, Cell, 111, 319, 10.1016/S0092-8674(02)01047-4 · DOI
  41. Ebneth, 1998, Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease, J. Cell Biol., 143, 777, 10.1083/jcb.143.3.777 · DOI · Paper page
  42. Nuydens, 2002, Coexpression of GSK-3β corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau, Neurobiol. Dis., 9, 38, 10.1006/nbdi.2001.0454 · DOI
  43. Stamer, 2002, Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress, J. Cell Biol., 156, 1051, 10.1083/jcb.200108057 · DOI · Paper page
  44. Talmat-Amar, 2011, Important neuronal toxicity of microtubule-bound tau in vivo in Drosophila, Hum. Mol. Genet., 20, 3738, 10.1093/hmg/ddr290 · DOI
  45. Liu, 2011, Drosophila Acyl-CoA synthetase long-chain family member 4 regulates axonal transport of synaptic vesicles and is required for synaptic development and transmission, J. Neurosci., 31, 2052, 10.1523/JNEUROSCI.3278-10.2011 · DOI
  46. Wagh, 2006, Bruchpilot, a protein with homology to ELKS/CAST, is required for structural integrity and function of synaptic active zones in Drosophila, Neuron, 49, 833, 10.1016/j.neuron.2006.02.008 · DOI · Paper page
  47. Horiuchi, 2007, Control of a kinesin-cargo linkage mechanism by JNK pathway kinases, Curr. Biol., 17, 1313, 10.1016/j.cub.2007.06.062 · DOI
  48. Schulz-Schaeffer, 2010, The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia, Acta Neuropathol., 120, 131, 10.1007/s00401-010-0711-0 · DOI · Paper page
  49. Kramer, 2008, Selective detection, quantification, and subcellular location of α-synuclein aggregates with a protein aggregate filtration assay, BioTechniques, 44, 403, 10.2144/000112691 · DOI
  50. Davidson, 1998, Stabilization of α-synuclein secondary structure upon binding to synthetic membranes, J. Biol. Chem., 273, 9443, 10.1074/jbc.273.16.9443 · DOI
  51. Jenco, 1998, Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins, Biochemistry, 37, 4901, 10.1021/bi972776r · DOI
  52. Bonini, 2005, Snaring the function of α-synuclein, Cell, 123, 359, 10.1016/j.cell.2005.10.017 · DOI
  53. Burre, 2010, α-synuclein promotes SNARE-complex assembly in vivo and in vitro, Science, 329, 1663, 10.1126/science.1195227 · DOI
  54. Chandra, 2005, α-synuclein cooperates with CSPα in preventing neurodegeneration, Cell, 123, 383, 10.1016/j.cell.2005.09.028 · DOI
  55. Darios, 2010, α-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis, EMBO Rep., 11, 528, 10.1038/embor.2010.66 · DOI
  56. Engelender, 1999, Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions, Nat. Genet., 22, 110, 10.1038/8820 · DOI
  57. Garcia-Reitbock, 2010, SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease, Brain, 133, 2032, 10.1093/brain/awq132 · DOI
  58. Scott, 2010, A pathologic cascade leading to synaptic dysfunction in α-synuclein-induced neurodegeneration, J. Neurosci., 30, 8083, 10.1523/JNEUROSCI.1091-10.2010 · DOI
  59. Sousa, 2009, α-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics, Mol. Biol. Cell, 20, 3725, 10.1091/mbc.E08-03-0302 · DOI
  60. Gureviciene, 2007, Role of alpha-synuclein in synaptic glutamate release, Neurobiol. Dis., 28, 83, 10.1016/j.nbd.2007.06.016 · DOI
  61. Nemani, 2010, Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis, Neuron, 65, 66, 10.1016/j.neuron.2009.12.023 · DOI
  62. Binder, 1985, The distribution of tau in the mammalian central nervous system, J. Cell Biol., 101, 1371, 10.1083/jcb.101.4.1371 · DOI · Paper page
  63. Thies, 2007, Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1, J. Neurosci., 27, 2896, 10.1523/JNEUROSCI.4674-06.2007 · DOI · Paper page
  64. Chee, 2005, Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions, Neurobiol. Dis., 20, 918, 10.1016/j.nbd.2005.05.029 · DOI
  65. Akbergenova, 2010, Synapsin regulates vesicle organization and activity-dependent recycling at Drosophila motor boutons, Neuroscience, 170, 441, 10.1016/j.neuroscience.2010.07.021 · DOI
  66. Wang, 2005, Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2, J. Neurosci., 25, 1219, 10.1523/JNEUROSCI.4660-04.2005 · DOI · Paper page
  67. Iseki, 1999, Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease, Neurosci. Lett., 265, 9, 10.1016/S0304-3940(99)00178-0 · DOI
  68. Yogev, 2008, Drosophila EGFR signalling is modulated by differential compartmentalization of Rhomboid intramembrane proteases, EMBO J., 27, 1219, 10.1038/emboj.2008.58 · DOI
  69. Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
  70. Bruijn, 1998, Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1, Science, 281, 1851, 10.1126/science.281.5384.1851 · DOI
  71. Forman, 2004, Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs, Nat. Med., 10, 1055, 10.1038/nm1113 · DOI · Paper page
  72. Soto, 2006, Amyloids, prions and the inherent infectious nature of misfolded protein aggregates, Trends Biochem. Sci., 31, 150, 10.1016/j.tibs.2006.01.002 · DOI
  73. Orr, 2007, Trinucleotide repeat disorders, Annu. Rev. Neurosci., 30, 575, 10.1146/annurev.neuro.29.051605.113042 · DOI
  74. Wills, 2011, Tauopathic changes in the striatum of A53T alpha-synuclein mutant mouse model of Parkinson's disease, PLoS ONE, 6, e17953, 10.1371/journal.pone.0017953 · DOI
  75. Bowie, 2004, Membrane proteins: a new method enters the fold, Proc. Natl. Acad. Sci. USA, 101, 3995, 10.1073/pnas.0400671101 · DOI
  76. Molloy, 1998, Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis, Electrophoresis, 19, 837, 10.1002/elps.1150190539 · DOI
  77. Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 · DOI · Paper page
  78. Kruger, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet., 18, 106, 10.1038/ng0298-106 · DOI · Paper page
  79. Zarranz, 2004, The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol., 55, 164, 10.1002/ana.10795 · DOI · Paper page
  80. Ibanez, 2004, Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease, Lancet, 364, 1169, 10.1016/S0140-6736(04)17104-3 · DOI
  81. Singleton, 2003, alpha-Synuclein locus triplication causes Parkinson's disease, Science, 302, 841, 10.1126/science.1090278 · DOI · Paper page
  82. Ingram, 2002, Tau gene mutations: dissecting the pathogenesis of FTDP-17, Trends Mol. Med., 8, 555, 10.1016/S1471-4914(02)02440-1 · DOI
  83. Chatterjee, 2009, Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model, Hum. Mol. Genet., 18, 164, 10.1093/hmg/ddn326 · DOI · Paper page
  84. Wills, 2012, Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways, PLoS ONE, 7, e30745, 10.1371/journal.pone.0030745 · DOI
  85. Jensen, 1999, α-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356, J. Biol. Chem., 274, 25481, 10.1074/jbc.274.36.25481 · DOI · Paper page
  86. Benussi, 2005, Interaction between tau and α-synuclein proteins is impaired in the presence of P301L tau mutation, Exp. Cell Res., 308, 78, 10.1016/j.yexcr.2005.04.021 · DOI
  87. Ubhi, 2007, A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies, Invert. Neurosci., 7, 165, 10.1007/s10158-007-0052-4 · DOI
  88. Chau, 1998, The microtubule-associated protein tau cross-links to two distinct sites on each α and β tubulin monomer via separate domains, Biochem., 37, 17692, 10.1021/bi9812118 · DOI
  89. Zhou, 2010, Molecular interaction of α-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells, Mol. Biol. Rep., 37, 3183, 10.1007/s11033-009-9899-2 · DOI
  90. Alim, 2004, Demonstration of a role for α-synuclein as a functional microtubule-associated protein, J. Alz. Dis., 6, 435, 10.3233/JAD-2004-6412 · DOI
  91. Selkoe, 2002, Alzheimer's disease is a synaptic failure, Science, 298, 789, 10.1126/science.1074069 · DOI · Paper page
  92. Calabresi, 2007, Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits, Parkins. Rel. Dis., 13, S259, 10.1016/S1353-8020(08)70013-0 · DOI
  93. Lee, 2010, LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction, J. Neurosci., 30, 16959, 10.1523/JNEUROSCI.1807-10.2010 · DOI
  94. Godena, 2011, TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization, PLoS ONE, 6, e17808, 10.1371/journal.pone.0017808 · DOI
  95. Fortin, 2004, Lipid rafts mediate the synaptic localization of α-synuclein, J. Neurosci., 24, 6715, 10.1523/JNEUROSCI.1594-04.2004 · DOI
  96. Perlmutter, 2009, Curvature dynamics of α-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms, J. Biol. Chem., 284, 7177, 10.1074/jbc.M808895200 · DOI
  97. van Rooijen, 2010, Membrane interactions of oligomeric α-synuclein: potential role in Parkinson's disease, Curr. Prot. Pept. Sci., 11, 334, 10.2174/138920310791330659 · DOI
  98. van Rooijen, 2010, Membrane permeabilization by oligomeric α-synuclein: in search of the mechanism, PLoS ONE, 5, e14292, 10.1371/journal.pone.0014292 · DOI
  99. Zhu, 2003, The association of α-synuclein with membranes affects bilayer structure, stability, and fibril formation, J. Biol. Chem., 278, 40186, 10.1074/jbc.M305326200 · DOI
  100. Alim, 2002, Tubulin seeds α-synuclein fibril formation, J. Biol. Chem., 277, 2112, 10.1074/jbc.M102981200 · DOI
  101. Kim, 2008, Impairment of microtubule system increases α-synuclein aggregation and toxicity, Biochem. Biophys. Res. Commun., 365, 628, 10.1016/j.bbrc.2007.11.020 · DOI
  102. Takahashi, 1999, Identification of three conserved regions in the DREF transcription factors from Drosophila melanogaster and Drosophila virilis, Nucleic Acids Res., 27, 510, 10.1093/nar/27.2.510 · DOI
  103. Friggi-Grelin, 2003, Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase, J. Neurobiol., 54, 618, 10.1002/neu.10185 · DOI
  104. Lin, 1994, Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance, Neuron, 13, 507, 10.1016/0896-6273(94)90022-1 · DOI
  105. Aberle, 2002, wishful thinking encodes a BMP type II receptor that regulates synaptic growth in Drosophila, Neuron, 33, 545, 10.1016/S0896-6273(02)00589-5 · DOI
  106. Keller, 2011, Glial-derived prodegenerative signaling in the Drosophila neuromuscular system, Neuron, 72, 760, 10.1016/j.neuron.2011.09.031 · DOI
  107. Jhaveri, 2000, Mechanisms underlying olfactory neuronal connectivity in Drosophila: the atonal lineage organizes the periphery while sensory neurons and glia pattern the olfactory lobe, Dev. Biol., 226, 73, 10.1006/dbio.2000.9855 · DOI
  108. Wu, 2006, A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining, Nat. Prot., 1, 2110, 10.1038/nprot.2006.336 · DOI
  109. Marrus, 2004, Differential localization of glutamate receptor subunits at the Drosophila neuromuscular junction, J. Neurosci., 24, 1406, 10.1523/JNEUROSCI.1575-03.2004 · DOI
  110. Wairkar, 2008, Synaptic defects in a Drosophila model of congenital muscular dystrophy, J. Neurosci., 28, 3781, 10.1523/JNEUROSCI.0478-08.2008 · DOI
  111. Daniels, 2004, Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content, J. Neurosci., 24, 10466, 10.1523/JNEUROSCI.3001-04.2004 · DOI
  112. Sang, 2005, Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis, Hum. Mol. Genet., 14, 357, 10.1093/hmg/ddi032 · DOI
  113. Sang, 2007, A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine, J. Neurosci., 27, 981, 10.1523/JNEUROSCI.4810-06.2007 · DOI
  114. Viquez, 2009, PP2A and GSK-3beta act antagonistically to regulate active zone development, J. Neurosci., 29, 11484, 10.1523/JNEUROSCI.5584-08.2009 · DOI
  115. Jan, 1982, Antibodies to horseradish peroxidase as specific neuronal markers in Drosophila and in grasshopper embryos, Proc. Natl. Acad. Sci. USA, 79, 2700, 10.1073/pnas.79.8.2700 · DOI

Cited by

Sorted by citations

Metadata

Authors
Roy, B., & Jackson, G. R.
Venue
Human Molecular Genetics
Publisher
Oxford University Press (OUP)
Published
2014-01-14
Volume
23
Issue
11
Pages
3008-3023
ISSN
  • 1460-2083
  • 0964-6906
DOI
10.1093/hmg/ddu011
Cited by
75
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review